CONVECTION-ENHANCED DELIVERY OF THERAPEUTIC AGENTS TO THE PUTAMEN
CONVECTION-ENHANCED DELIVERY OF THERAPEUTIC AGENTS TO THE PUTAMEN
批准号:
8358217
负责人:
MARINA EMBORG
金额:
$3.91万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30
关键词:
3-DimensionalAtlasesAutopsyBehavioralBiological AssayBiopsyBrainCathetersCell NucleusCellsClinicConvectionDeep Brain StimulationElectrodesEnsureFundingGadolinium DTPAGelGoalsGrantHumanImageImageryIndividualInfusion proceduresMRI ScansMacaca mulattaMagnetic Resonance ImagingMethodsMonitorMonkeysNational Center for Research ResourcesNavigation SystemOperative Surgical ProceduresPharmaceutical PreparationsPositioning AttributePrimatesPrincipal InvestigatorPrintingProceduresProtocols documentationReportingResearchResearch InfrastructureResourcesSalineScanningSecureServicesSolutionsSourceSterilityStructureSystemTechniquesTechnologyTherapeutic AgentsTimeUnited States National Institutes of HealthVariantWisconsinbasecaudate nucleuscostcraniumdesignflexibilitygadoteridolin vivointraoperative imagingnonhuman primatepre-clinicalpreclinical evaluationputamenstemsuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Objective: To design a successful convection-enhanced infusion protocol for human intra-putamenal infusions of solutions carrying drugs.
Success means, in this context, covering the putamen and/or caudate nucleus, with minimal coverage of surrounding structures. The goal of this particular study is to develop such a protocol in rhesus monkeys, and to offer a prediction for the results of a similar protocol in humans. We will estimate the likelihood of achieving a given coverage using this protocol. We are also specifically comparing current proposed methods of brain delivery.
We have established all the infusion methods and are performing routing infusions and gels in nonhuman primates using intraoperative imaging.
PROGRESS:
Due to their behavioral and anatomical complexity nonhuman primates are ideal subjects for preclinical evaluation of invasive technologies requiring intracerebral targeting. While stereotaxic atlases provide basic information, the individual variability between rhesus monkey subjects necessitates the use of MRI-guided surgical techniques. This need is further enhanced when studying in vivo dynamics of infusates in the brain parenchyma. During in vivo infusions, the ability to perform accurate targeting towards a 3-D specific point of the targeted structure allows control of the anatomical variable and identification of the effects of variations in other factors. Real-time MRI navigation systems, such as the Medtronic Navigation System, are currently being used in the clinic for intracerebral biopsies and placement of electrodes for deep brain stimulation, yet their use in nonhuman primates and MRI monitoring of intracerebral infusions has not been reported. In this study rhesus monkeys (5-7 yrs. old, 5-8 kg) were placed in a MRI-compatible stereotaxic frame. T1 MRIs were obtained in a 3.0T GE scanner in the axial, coronal and sagittal planes to identify the target in the center of the putamen nucleus. Under sterile surgical conditions, a hole in the monkey skull was drilled at the entry point defined by the baseline MRI. The base of a Navigus (a MRI-compatible trajectory guide, part of the Medtronic Navigation system) that was modified to adapt to the curvature of the monkey skull was secured on top. Prior to introduction, the catheter and infusion lines were filled with a solution of Gadolinium DTPA (gadoteridol; diluted in saline to 2mMol/l) and bromophenol blue (0.16 mg/ml). Scans were taken to define the position of the Navigus stem. When the projection of the catheter in the three planes matched the desired trajectory to the target, the base was locked in position. Successive MRI scans were performed to confirm trajectory of the catheter and to ensure single direct passage to target. Additional scans were performed during infusion. Postmortem visualization of bromophenol blue matched in vivo imaging. Our results in nonhuman primates confirm the accuracy of real-time MRI intracerebral navigation combined with a flexible targeting system like the Navigus and suggests that it can be a valuable tool for preclinical intracerebral procedures.
This research used WNPRC Assay Services and CPI.
PUBLICATION:
Emborg M.E., Joers V., Fisher R., Brunner K., Carter V., Ross C., Rhagavan R., Raschke J., Brady M., Kubota K., Alexander A.. (2010) Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates. Cell Transpl. Jun 29. [Epub ahead of print]. PMID 20587170.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
-
批准号:9789388
-
项目类别:
-
资助金额:$75.05万
-
财政年份:2018
-
负责人:MARINA EMBORG
-
依托单位:
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
-
批准号:10455343
-
项目类别:
-
资助金额:$119.21万
-
财政年份:2018
-
负责人:MARINA EMBORG
-
依托单位:
Transgenic marmosets for translational stem cell research
-
批准号:9215707
-
项目类别:
-
资助金额:$67.04万
-
财政年份:2015
-
负责人:MARINA EMBORG
-
依托单位:
Activation of PPAR-gamma in a Monkey Model of Cardiac Dysautonomia
-
批准号:8835160
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2014
-
负责人:MARINA EMBORG
-
依托单位:
Activation of PPAR-gamma in a Monkey Model of Cardiac Dysautonomia
-
批准号:8698569
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2014
-
负责人:MARINA EMBORG
-
依托单位:
OPTIMIZING THE DELIVERY OF GENE THERAPY FOR PARKINSON?S DISEASE
-
批准号:8358240
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2011
-
负责人:MARINA EMBORG
-
依托单位:
NEUROPROTECTIVE PROPERTIES OF SELECTIVE PPAR GAMMA AGONIST LY554862
-
批准号:8358230
-
项目类别:
-
资助金额:$3.91万
-
财政年份:2011
-
负责人:MARINA EMBORG
-
依托单位:
INDIVIDUALIZED STEM CELL THERAPY FOR PARKINSON?S DISEASE
-
批准号:8358231
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2011
-
负责人:MARINA EMBORG
-
依托单位:
HEART DYSAUTONOMIA IN PARKINSON'S DISEASE
-
批准号:8358232
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2011
-
负责人:MARINA EMBORG
-
依托单位:
HEART DYSAUTONOMIA IN PARKINSON'S DISEASE
-
批准号:8173143
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
INDIVIDUALIZED STEM CELL THERAPY FOR PARKINSON?S DISEASE
-
批准号:8173142
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
LENTIVIRAL DELIVERY OF GDNF AND BCL-2 FOR PARKINSON?S DISEASE
-
批准号:8173083
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
TRANSPLANTATION OF ES CELLS-DERIVED DOPAMINERGIC NEURONS
-
批准号:8173091
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
PIOGLITAZONE CSF PENETRATION TO TREAT PARKINSON'S DISEASE
-
批准号:8173141
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
CONVECTION-ENHANCED DELIVERY OF THERAPEUTIC AGENTS TO THE PUTAMEN
-
批准号:8173120
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
ACTIVATION OF NRF2 NEUROPROTECTIVE PATHWAYS FOR PARKINSON?S DISEASE
-
批准号:8173092
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
NEUROPROTECTIVE PROPERTIES OF SELECTIVE PPAR GAMMA AGONIST LY554862
-
批准号:8173140
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
OPTIMIZING THE DELIVERY OF GENE THERAPY FOR PARKINSON?S DISEASE
-
批准号:8173168
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
PRECLINICAL PARKINSON?S RESEARCH PROGRAM
-
批准号:8173119
-
项目类别:
-
资助金额:$10.33万
-
财政年份:2010
-
负责人:MARINA EMBORG
-
依托单位:
PRECLINICAL PARKINSON?S RESEARCH PROGRAM
-
批准号:7958799
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2009
-
负责人:MARINA EMBORG
-
依托单位:
海外基金